New Prognostic and Predictive Markers in Cancer Progression |
Autore | Costantini Susan |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
Descrizione fisica | 1 electronic resource (294 p.) |
Soggetto topico | Medicine |
Soggetto non controllato |
MSI2
OSCC oral cancer musashi 2 prognosis N-cadherin EMT breast cancer new metastasis eribulin blood biomarker bladder cancer immune checkpoint inhibitor CD8+ T effector cells microRNA biomarkers head and neck cancer laryngeal cancer prediction metastasis lifestyle habit chemo-/radio resistance therapeutic target AKT AR castration-resistant prostate cancer (CRPC) MAPK mTOR PI3K prostate cancer therapeutic resistance WNT miRNA melanoma melanoma resistance to MAPK/MEK inhibitors resistance to immune checkpoint inhibitors TNBC BRCA1/2 HRR PDL1 TILs PI3KCA PTEN CTCs CSC pancreatic cancer K-RAS oncogene oncogene dependency targeted therapies genomic mutations transcriptomics metabolomics selenoproteins cancer HUB nodes major histocompatibility complex (MHC) human leukocyte antigen (HLA) antigen processing machinery (APM) molecules carcinogenesis tumor predisposition cancer immunotherapy pheochromocytoma paraganglioma head and neck neoplasms head and neck tumors genetic syndromes mutations hyperglycemia cardioncology nivolumab cytokines cardiotoxicity acetyltransferase cancer prognosis NAA10 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910557794803321 |
Costantini Susan
![]() |
||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Role of Medical Imaging in Cancers . Volume 1 |
Autore | Fanti Stefano |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
Descrizione fisica | 1 electronic resource (312 pages) |
Soggetto topico | Medicine |
Soggetto non controllato |
positron emission tomography
head and neck neoplasms neovascularization pathologic PET/CT urothelial carcinoma bladder cancer upper tract urothelial carcinoma survival PET PSMA prostate DCFPyL DCFBC PSMA-1007 ovarian cancer relapse SUVmax targeted therapy prognosis soft tissue sarcoma (STS) pazopanib dynamic 18F-FDG PET/CT SUV two-tissue compartment model magnetic resonance imaging machine learning diffusion perfusion texture analysis squamous cell carcinoma of the head and neck diffusion-weighted imaging malignant pleural mesothelioma pleural dissemination empyema pleural effusion mCRPC SPECT/CT Computer-assisted diagnosis XOFIGO Therapy response assessment circulating miRNAs breast cancer imaging parameters PET/MRI biomarkers triple negative breast cancer VCAM-1 SPECT imaging sdAbs Hounsfield unit computed tomography adipose tissue precision oncology FDG-PET/CT PERCIST metastatic breast cancer prostate cancer 18F-FACBC recurrence meta-analysis review meningioma somatostatin receptor neuroimaging radionuclide therapy breast imaging marker radiomics Yin Yang 1 PDAC Mesothelin noninvasive imaging receptor status molecular imaging nuclear medicine guidelines overutilization epistemology consensus mantle cell lymphoma 18F-FDG PET/CT Deauville criteria Radium-223 FDG castrate resistant prostate cancer programmed cell death 1 receptor diagnostic imaging CTLA-4 Antigen Immunotherapy Adoptive radioactive tracers radionuclide imaging CD8-Positive T-Lymphocytes PI-RADS diffusion kurtosis imaging dynamic contrast-enhanced magnetic resonance imaging 68Gallium-PSMA PET/CT prostate-specific-antigen PSA kinetics thresholds biochemical recurrence optimal cutoff level non-small-cell lung cancer circulating tumor cells immunotherapy response to treatment head and neck cancer HPV EBV p16 Molecular imaging miRNA expression radiogenomics radiomic diagnosis biomarker glioblastoma radiation therapy MRI diffusion tensor imaging Hodgkin lymphoma diffuse large B-cell lymphoma staging response assessment locally advanced cervical cancer concurrent chemoradiotherapy treatment response follow up cystic tumor International Consensus Guidelines intraductal papillary mucinous neoplasms pancreatic neoplasms PD-1 PD-L1 response to therapy NSCLC positron-emission tomography single-photon emission computed tomography immune checkpoint inhibitors gold nanoparticle heat shock protein 70 spectral-CT |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910557432103321 |
Fanti Stefano
![]() |
||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Role of Medical Imaging in Cancers . Volume 2 |
Autore | Fanti Stefano |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
Descrizione fisica | 1 electronic resource (228 p.) |
Soggetto topico | Medicine |
Soggetto non controllato |
positron emission tomography
head and neck neoplasms neovascularization pathologic PET/CT urothelial carcinoma bladder cancer upper tract urothelial carcinoma survival PET PSMA prostate DCFPyL DCFBC PSMA-1007 ovarian cancer relapse SUVmax targeted therapy prognosis soft tissue sarcoma (STS) pazopanib dynamic 18F-FDG PET/CT SUV two-tissue compartment model magnetic resonance imaging machine learning diffusion perfusion texture analysis squamous cell carcinoma of the head and neck diffusion-weighted imaging malignant pleural mesothelioma pleural dissemination empyema pleural effusion mCRPC SPECT/CT Computer-assisted diagnosis XOFIGO Therapy response assessment circulating miRNAs breast cancer imaging parameters PET/MRI biomarkers triple negative breast cancer VCAM-1 SPECT imaging sdAbs Hounsfield unit computed tomography adipose tissue precision oncology FDG-PET/CT PERCIST metastatic breast cancer prostate cancer 18F-FACBC recurrence meta-analysis review meningioma somatostatin receptor neuroimaging radionuclide therapy breast imaging marker radiomics Yin Yang 1 PDAC Mesothelin noninvasive imaging receptor status molecular imaging nuclear medicine guidelines overutilization epistemology consensus mantle cell lymphoma 18F-FDG PET/CT Deauville criteria Radium-223 FDG castrate resistant prostate cancer programmed cell death 1 receptor diagnostic imaging CTLA-4 Antigen Immunotherapy Adoptive radioactive tracers radionuclide imaging CD8-Positive T-Lymphocytes PI-RADS diffusion kurtosis imaging dynamic contrast-enhanced magnetic resonance imaging 68Gallium-PSMA PET/CT prostate-specific-antigen PSA kinetics thresholds biochemical recurrence optimal cutoff level non-small-cell lung cancer circulating tumor cells immunotherapy response to treatment head and neck cancer HPV EBV p16 Molecular imaging miRNA expression radiogenomics radiomic diagnosis biomarker glioblastoma radiation therapy MRI diffusion tensor imaging Hodgkin lymphoma diffuse large B-cell lymphoma staging response assessment locally advanced cervical cancer concurrent chemoradiotherapy treatment response follow up cystic tumor International Consensus Guidelines intraductal papillary mucinous neoplasms pancreatic neoplasms PD-1 PD-L1 response to therapy NSCLC positron-emission tomography single-photon emission computed tomography immune checkpoint inhibitors gold nanoparticle heat shock protein 70 spectral-CT |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910557309503321 |
Fanti Stefano
![]() |
||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|